Tag Archive for: Sofinnova

What Next After A Year Of Innovation And Growth?

/in

As part of its ‘Pharma Outlook for 2022’, leading healthcare publication, In Vivo, explored the outlook for US and EU venture capital funding in biopharma.  Asking whether the sector can keep the momentum going for investments, it drew on the experience and insight of prominent investors [many among them our clients,] to provide comment on […]

Read more

Accessing European Investment in a Post Covid-19 World

/in

A video panel by Optimum in partnership with One Nucleus for ON Helix event held virtually in July 2020

Read more

Optimum European Healthcare Investor Survey

/in ,

European investors continue actively investing in healthcare. The survey held in May 2020 includes responses from 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector.

Read more